Your daily dose of Austin
×
Make your inbox more Austin.
Local news and fun, every day 6am.
test tubes
(Giovanni Cancemi/Adobe)

Austin-based medical technology company Babson Diagnostics has received emergency use authorization from the Food & Drug Administration for its COVID-19 antibody test, the company announced Thursday.


Babson is one of five clinical labs to have received an EUA for an antibody test.

Such tests can help detect whether a person has been exposed to COVID-19 and developed antibodies in response.

The Babson test is currently the subject of clinical studies, including at Dell Medical School at the University of Texas at Austin.

Other companies—including local health care providers such as Total Men's Primary Care, Remedy and Victory Medical—have offered antibody testing for months, but FDA approval has been rare.

Researchers are still studying COVID-19 and have yet to answer questions about how long immunity to the virus may last. But the tests are also useful for identifying potential convalescent plasma donors, whose antibodies may help treat COVID-19 patients.

Babson plans to use its current antibody test as a building block, refining it as its researchers learn more about COVID-19 and its pathology.

Popular

New mothers step up to donate breast milk as Austin weathers formula shortage

(Pexels)

Austin parents and grocery store shelves are feeling the effects of a nationwide baby formula shortage.

Keep Reading Show less
Get ready to see driverless vehicles as Argo AI launches new pilot in Austin

(Argo AI)

Next time you’re sitting at a red light in Austin, you may look over and see a car without a person at the driver’s wheel.

Keep Reading Show less